Growth Hormone Peptides

CJC-1295 (No DAC)

Also known as: Mod-GRF(1-29) · Modified GRF 1-29 · CJC-1295 without DAC

The short-acting GHRH analog with a ~30-minute plasma half-life

Molecular Data

Molecular Weight3367.97 Da
Amino Acids29 residues
FormulaC152H252N44O42
CAS Number863288-34-0
Half-Life~30 minutes (plasma, estimated)
Purity≥99% HPLC

Overview

CJC-1295 without DAC (also known as Mod-GRF 1-29) is a modified form of the first 29 amino acids of growth hormone-releasing hormone (GHRH). Four amino acid substitutions confer resistance to dipeptidyl peptidase IV (DPP-IV) cleavage, extending its half-life relative to native GHRH(1-29) while preserving the short-acting, pulsatile GH release profile.

Mechanism of Action

CJC-1295 (No DAC) binds the GHRH receptor on somatotroph cells in the anterior pituitary, stimulating pulsatile GH release. The four amino acid modifications (Ala at position 2, Ala at 8, Ala at 15, Leu at 27) protect against DPP-IV enzymatic degradation. The short half-life preserves physiological GH pulsatility, which is considered important for maintaining receptor sensitivity.

Research Summary

CJC-1295 (No DAC) is frequently studied in combination with ipamorelin to produce synergistic GH release — GHRH and GHRP acting on complementary pathways. Research in rodent models has examined effects on body composition, bone density, and IGF-1 levels. The compound is distinguished from CJC-1295 with DAC, which has a multi-day half-life and produces non-pulsatile GH elevation.

Amino Acid Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

Key Published Research

1

CJC-1295, a long-acting growth hormone-releasing hormone analog

Journal of Clinical Endocrinology & Metabolism · 2006

Demonstrated sustained GH and IGF-1 elevation in healthy adults (DAC form)

2

Growth hormone-releasing hormone analogs: clinical applications

Endocrine Reviews · 2010

Comprehensive review of GHRH analog pharmacology and research applications

Frequently Asked Questions

What is CJC-1295 (No DAC) used for in research?

CJC-1295 (No DAC) is studied in preclinical research for its role in growth hormone peptides. CJC-1295 (No DAC) is frequently studied in combination with ipamorelin to produce synergistic GH release — GHRH and GHRP acting on complementary pathways.

What is the molecular weight of CJC-1295 (No DAC)?

CJC-1295 (No DAC) has a molecular weight of 3367.97 Da and consists of 29 amino acids with the formula C152H252N44O42.

How should CJC-1295 (No DAC) be stored?

−20°C, sealed, protected from light. Stable ≤24 months lyophilized.

What is the half-life of CJC-1295 (No DAC)?

The estimated half-life of CJC-1295 (No DAC) is ~30 minutes (plasma, estimated). Note that half-life data is derived from preclinical or early-phase research and may vary by route of administration.

What purity standard is used for research-grade CJC-1295 (No DAC)?

Research-grade CJC-1295 (No DAC) is typically supplied at ≥99% HPLC as verified by HPLC analysis. Third-party certificate of analysis (CoA) documentation should always be requested from suppliers.

Research Use Only: All information on this page is provided for educational and scientific research purposes only. CJC-1295 (No DAC) is not approved by the FDA for human use unless otherwise noted. This content does not constitute medical advice. Always consult a qualified healthcare professional before making any health-related decisions.
Research-Grade Supply

Source CJC-1295 (No DAC)

Peptriva supplies ≥99% HPLC-verified CJC-1295 (No DAC) with ISO 17025 third-party CoA, same-day shipping from California.

View CJC-1295 (No DAC) at PeptrivaBrowse Full CatalogCheck your COA
≥99% HPLC Purity
ISO 17025 CoA
Same-Day Shipping (CA)
Secure Checkout

Storage & Handling

−20°C, sealed, protected from light. Stable ≤24 months lyophilized.

Half-Life

~30 minutes (plasma, estimated)